B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 29.05 SEK -1.19% Market Closed
Market Cap: 1.9B SEK

BioInvent International AB
Investor Relations

BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

Show more
Loading
BINV
OMX Stockholm 30
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Martin Welschof Ph.D.
President & CEO
No Bio Available
Mr. Stefan Ericsson M.B.A.
Chief Financial Officer
No Bio Available
Ms. Marie Moores M.Sc., R.G.N.
Chief Operating Officer
No Bio Available
Mr. Kristoffer Rudenholm Hansson
Senior Vice President of Technical Operations
No Bio Available
Mr. Björn Frendéus
Chief Scientific Officer
No Bio Available
Ms. Cecilia Hofvander
Senior Director of Investor Relations
No Bio Available
Dr. Andres McAllister
Chief Medical Officer
No Bio Available
Ms. Ingrid Teige
Head of Preclinical Research
No Bio Available
Ms. Sylvie Ryckebusch
Chief Business Officer
No Bio Available
Dr. Ingunn Munch Lindvig
Senior Vice President of Regulatory Affairs
No Bio Available

Contacts

Address
SKANE
Lund
Gammahuset, Ideongatan 1
Contacts
+46462868550.0
www.bioinvent.se
sparklesyt

See Also

Summary
BINV intrinsic value, competitors valuation, and company profile.
DCF Valuation
BINV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BINV stock valuation using valuation multiples.
Wall Street Estimates
BINV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BINV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.